Skip to main content
Log in

Allele Specific PCR: A Cost Effective Screening Method for MPL Mutations in Myeloproliferative Neoplasms

  • Correspondence
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391–2405

    Article  CAS  PubMed  Google Scholar 

  2. Pardanani AD, Levine RL, Lasho T, Pikman Y, Mesa RA, Wadleigh M et al (2006) MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood 108(10):3472–3476

    Article  CAS  PubMed  Google Scholar 

  3. Pikman Y, Lee BH, Mercher T, McDowell E, Ebert BL, Gozo M et al (2006) MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Med 3(7):e270

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Boyd EM, Bench AJ, Fernandez AG, Anand S, Vaghela KJ, Beer P et al (2010) Clinical utility of routine MPL exon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis. Br J Haematol 149(2):250–257

    Article  CAS  PubMed  Google Scholar 

  5. Furtado LV, Weigelin HC, Elenitoba-Johnson KS, Betz BL (2013) Detection of MPL mutations by a novel allele-specific PCR-based strategy. J Mol Diagn 15(6):810–818

    Article  CAS  PubMed  Google Scholar 

  6. Alchalby H, Badbaran A, Bock O, Fehse B, Bacher U, Zander AR, Kroger N (2010) Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT. Bone Marrow Transplant 45(9):1404–1407

    Article  CAS  PubMed  Google Scholar 

  7. Hussein K, Bock O, Theophile K, Schulz Bischof K, Porwit A, Schlue J, Jonigk D, Kreipe H (2009) MPLW515L mutation in acute megakaryoblastic leukaemia. Leukemia 23(5):852–855

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Poonkuzhali Balasubramanian.

Ethics declarations

Conflict of interest

The authors have no competing interest.

Ethical Approval

This is a retrospective analysis using DNA extracted from EDTA blood sample that has been collected for routine molecular diagnostic procedures (JAK2, CALR) in patients with myeloproliferative neoplasms in our institution. No additional sample was collected from any patient for this study. All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (JPEG 81 kb)

Supplementary material 2 (DOCX 13 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arunachalam, A.K., Suresh, H., Mathews, V. et al. Allele Specific PCR: A Cost Effective Screening Method for MPL Mutations in Myeloproliferative Neoplasms. Indian J Hematol Blood Transfus 34, 765–767 (2018). https://doi.org/10.1007/s12288-018-0982-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-018-0982-5

Keywords

Navigation